NorthWest Biotherapeutics Inc (NWBO)

[GPha]

I do understand the frustration regarding the volatility of the price, delays in results, and lack of communication. From my experience, they are doing the right thing. I've been involved in the industry and have been involved in most aspects related to it. I've been in marketing, regulatory affairs, retails, research and I'm a member of many committees involved in evaluating many drugs from a pharmacoeconomic perspective and efficacy to give them approval in my country. They have an emerging technology highly likely a game-changer they should not release the data in a brief manner which can easily miss interpreted by many biased KOL. They need to do it as slow as they can and to validate every information they provide to the journal. because highly likely the data they will provide is something never seen before due to the unique MOA of this technology to cover the genetic heterogeneity in Glioblastoma. I know my post is biased but it's my educated opinion.

Hope the best for the patients and then for the investors within this company.